ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Genomic Test More Accurate In Predicting Metastasis Than PSA, Tumor Stage & Grade

February 22, 2013

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

Trials Approved by NCI CTEP Last Month

November 25, 2011

In Brief: Hopkins Gets $10 Million for Directorships, to Dedicate New Clinical Cancer Building

October 22, 1999

Obit: Former Roswell Park Director Gerald Murphy, 65, In Tel Aviv.

January 28, 2000

Hammer Blast GAO Report As ”Gobblygook”

June 12, 1987